Gaukhar M. Yusubalieva

Author

Also Known As

G M Yusubalieva, G. M Yusubalieva, G. M. Yusubalieva, G. Yusubalieva, G. М. Yusubalieva, G.M. Yusubalieva, GM Yusubalieva, Gauhar M. Yusubalieva, Gaukhar M. Yusubalieva, Gaukhar M Yusubalieva

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Federal Medical-Biological Agency Ministry of Health of the Russian Federation Federal Medical Research Centre for Psychiatry and Narcology Lomonosov Moscow State University Engelhardt Institute of Molecular Biology

About

Gaukhar M. Yusubalieva is an author at Federal Medical-Biological Agency specializing in medicine, glioma, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	547
2	Engineering	5	5	285
3	Biomedical Engineering	4	4	156
4	Natural Sciences	2	2	34
5	Health Sciences	1	1	21

Gaukhar M. Yusubalieva

Publications

825

Citations

H-Index

Page 1

	Year	Citations
Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer Athina Kilpeläinen, Stefan Petkov, Maxim A. Abakumov, Scientific Reports EngineeringOncologic ImagingImmunologyImmunoeditingCancer Biology	2017	129
Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1 N. V. Nukolova, A. S. Khalansky, Gaukhar M. Yusubalieva, Drug Delivery EngineeringHigh-grade GliomasBiomedical EngineeringGliomaCisplatin-loaded Nanogels	2014	68
Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43 Gaukhar M. Yusubalieva, Anastasia E. Belorusova, М. V. Gulyaev, Nanomedicine Nanotechnology Biology and Medicine NanoparticlesNanomedicineNeuro-oncologyExtracellular LoopEngineering	2011	62
Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19 Maria G. Byazrova, Gaukhar M. Yusubalieva, Anna Spiridonova, Clinical & Translational Immunology	2021	59
Modeling and immunohistochemical analysis of C6 glioma In Vivo Gaukhar M. Yusubalieva, Pavlov Ka, O. V. Ukhova Bulletin of Experimental Biology and Medicine Neuro-oncologyGliomaC6 GliomaBrain-immune InteractionMedicine	2007	44
Treatment of Poorly Differentiated Glioma Using a Combination of Monoclonal Antibodies to Extracellular Connexin-43 Fragment, Temozolomide, and Radiotherapy Gaukhar M. Yusubalieva, Yana Zorkina, G L Kobyakov, Bulletin of Experimental Biology and Medicine Neuro-oncologyTumoral PathologyTumor InnervationMedicinePathology	2014	41
Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies Gaukhar M. Yusubalieva, Eugene B. Tsitrin, Nadezhda Ph. Grinenko, Drug Delivery	2011	35
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern Andrey A. Gorchakov, Sergey V. Kulemzin, Sergey V. Guselnikov, Cell Discovery	2021	34
Effect of vitamin D3 supplementation on cellular immunity and inflammatory markers in COVID-19 patients admitted to the ICU Mikhail V. Bychinin, T. V. Klypa, Irina A. Mandel, Scientific Reports	2022	29
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov, Molecular Therapy — Oncolytics	2021	26

Page 1